4.5 Article

Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys

Related references

Note: Only part of the references are listed.
Review Psychiatry

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

D. Jeffrey Newport et al.

AMERICAN JOURNAL OF PSYCHIATRY (2015)

Article Behavioral Sciences

R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

Ji-chun Zhang et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)

Letter Neurosciences

Rapid antidepressant effects and abuse liability of ketamine

Chun Yang et al.

PSYCHOPHARMACOLOGY (2014)

Letter Neurosciences

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression

Kenji Hashimoto

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)

Article Psychiatry

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Nancy Diazgranados et al.

ARCHIVES OF GENERAL PSYCHIATRY (2010)

Review Endocrinology & Metabolism

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

Robert B. Innis et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)